株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポイントオブケア(POC)診断の世界市場:2019年~2023年

Global Point of Care (POC) Diagnostics Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 825206
出版日 ページ情報 英文 124 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.24円で換算しております。
Back to Top
ポイントオブケア(POC)診断の世界市場:2019年~2023年 Global Point of Care (POC) Diagnostics Market 2019-2023
出版日: 2019年04月05日 ページ情報: 英文 124 Pages
概要

高齢者人口の増加が、ポイントオブケア(POC)診断市場の今後の成長を牽引するでしょう。免疫系が年齢とともに悪化するにつれて、肺疾患、癌、および脳卒中などの疾患の罹患率が高齢者人口の間で高くなっています。免疫力と代謝力が低いため、高齢者は定期的に診断検査を受ける必要があります。POC診断装置が疾患の診断に役立ち、医師が適切な治療法を選択する助けとなるので、これはPOC診断装置の需要が増加するでしょう。結果として、高齢化人口の増加は、予測期間中にポイントオブケア(POC)診断市場の成長を牽引するでしょう。 Technavioのアナリストは、世界のポイントオブケア(POC)診断市場が2023年までに10%近くのCAGRで成長すると予測しています。

当レポートでは、世界のポイントオブケア(POC)診断市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 レポートの範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 製品別比較:市場規模および予測(2018年~2023年)
  • 血液診断
  • 感染症診断
  • 迅速心血管診断
  • 迅速凝固診断
  • その他
  • 市場機会:製品別

第7章 顧客情勢

第8章 市場セグメンテーション:エンドユーザー別

  • 病院・診療所
  • 在宅医療
  • 臨床診断検査室

第9章 地域情勢プ

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第12章 市場動向

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Sinocare Inc.

第15章 付録

  • 調査方法
  • 略語のリスト

第16章 TECHNAVIOについて

図表
  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Hematology diagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Hematology diagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Infectious disease diagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Infectious disease diagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Rapid cardiovascular diagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Rapid cardiovascular diagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Rapid coagulation diagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: Rapid coagulation diagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Market opportunity by product
  • Exhibit 30: Customer landscape
  • Exhibit 31: Market segmentation by end-user 2018
  • Exhibit 32: Market share by geography 2018-2023 (%)
  • Exhibit 33: Geographic comparison
  • Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 41: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: Key leading countries
  • Exhibit 43: Market opportunity
  • Exhibit 44: Factors contributing to infections among aging population
  • Exhibit 45: Impact of drivers and challenges
  • Exhibit 46: Vendor landscape
  • Exhibit 47: Landscape disruption
  • Exhibit 48: Vendors covered
  • Exhibit 49: Vendor classification
  • Exhibit 50: Market positioning of vendors
  • Exhibit 51: Abbott - Vendor overview
  • Exhibit 52: Abbott - Business segments
  • Exhibit 53: Abbott - Organizational developments
  • Exhibit 54: Abbott - Geographic focus
  • Exhibit 55: Abbott - Segment focus
  • Exhibit 56: Abbott - Key offerings
  • Exhibit 57: Danaher - Vendor overview
  • Exhibit 58: Danaher - Business segments
  • Exhibit 59: Danaher - Organizational developments
  • Exhibit 60: Danaher - Geographic focus
  • Exhibit 61: Danaher - Segment focus
  • Exhibit 62: Danaher - Key offerings
  • Exhibit 63: F. Hoffmann-La Roche Ltd - Vendor overview
  • Exhibit 64: F. Hoffmann-La Roche Ltd - Business segments
  • Exhibit 65: F. Hoffmann-La Roche Ltd - Organizational developments
  • Exhibit 66: F. Hoffmann-La Roche Ltd - Geographic focus
  • Exhibit 67: F. Hoffmann-La Roche Ltd - Segment focus
  • Exhibit 68: F. Hoffmann-La Roche Ltd - Key offerings
  • Exhibit 69: Siemens Healthineers AG - Vendor overview
  • Exhibit 70: Siemens Healthineers AG - Business segments
  • Exhibit 71: Siemens Healthineers AG - Organizational developments
  • Exhibit 72: Siemens Healthineers AG - Geographic focus
  • Exhibit 73: Siemens Healthineers AG - Segment focus
  • Exhibit 74: Siemens Healthineers AG - Key offerings
  • Exhibit 75: Sinocare Inc. - Vendor overview
  • Exhibit 76: Sinocare Inc. - Business segments
  • Exhibit 77: Sinocare Inc. - Organizational developments
  • Exhibit 78: Sinocare Inc. - Key offerings
  • Exhibit 79: Validation techniques employed for market sizing
目次
Product Code: IRTNTR31140

About this market

The growing geriatric population will drive the point of care (POC) diagnostics market growth in the forthcoming years. As the immune system deteriorates with age, the prevalence of diseases such as lung disease, cancer, and stroke are high among the aging population. Due to their low immunity and metabolism, the elderly requires diagnostic testing regularly. This will lead to an increase in the demand for POC diagnostic devices, as these devices assists in disease diagnosis and help the doctor choose the appropriate treatment option. As a result, the rising aging population will drive the point of care (POC) diagnostics market growth during the forecast period. Technavio's analysts have predicted that the point of care (POC) diagnostics market will register a CAGR of nearly 10% by 2023.

Market Overview

Increased focus on personalized medicine

One of the growth drivers of the global point of care (POC) diagnostics market is the increased focus on personalized medicine. The demand for personalized medicine is growing owing to the development of genome technology, whole genome technology, and companion diagnostics, which will increase the demand for diagnostic devices to diagnose diseases and perform treatment according to an individual's diagnostic response.

Stringent regulations

One of the challenges in the growth of the global point of care (POC) diagnostics market is the stringent regulations. Stringent government regulations in different countries affect the development and demand for devices such as POC diagnostics.

For the detailed list of factors that will drive and challenge the growth of the point of care (POC) diagnostics market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several hospitals and clinics are switching from conventional testing methods to POC testing due to their improved efficiency and faster turnaround times. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Hematology diagnostics - Market size and forecast 2018-2023
  • Infectious disease diagnostics - Market size and forecast 2018-2023
  • Rapid cardiovascular diagnostics - Market size and forecast 2018-2023
  • Rapid coagulation diagnostics - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Hospitals and clinics
  • Homecare settings
  • Clinical diagnostic laboratories

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Sinocare Inc.

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

PART 16: EXPLORE TECHNAVIO

Back to Top